Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Illumina Inc (NASDAQ:ILMN)

176.36
Delayed Data
As of Jun 27
 -4.53 / -2.50%
Today’s Change
119.37
Today|||52-Week Range
189.48
+37.74%
Year-to-Date
Illumina Shines as Another Biotech Winner
Jun 22 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close180.89
Today’s open180.31
Day’s range176.14 - 181.29
Volume716,658
Average volume (3 months)968,130
Market cap$25.8B
Dividend yield--
Data as of 06/27/2017

Growth & Valuation

Earnings growth (last year)-0.97%
Earnings growth (this year)+8.98%
Earnings growth (next 5 years)+14.41%
Revenue growth (last year)+8.05%
P/E ratio35.6
Price/Sales7.90
Price/Book11.73

Competitors

 Today’s
change
Today’s
% change
BIVVBioverativ Inc-0.51-0.84%
KITEKite Pharma Inc-2.38-2.37%
TECHBio-Techne Corp-0.43-0.36%
BLUEbluebird bio Inc-4.20-3.78%
Data as of 06/27/2017

Financials

Next reporting dateJuly 25, 2017
EPS forecast (this quarter)$0.69
Annual revenue (last year)$2.4B
Annual profit (last year)$454.1M
Net profit margin18.93%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Francis A. deSouza
Chief Financial Officer &
Senior Vice President
Sam A. Samad
Corporate headquarters
San Diego, California

Forecasts